Simon Walz
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Arnulf Stenzl (20 shared papers)Moritz Maas (12 shared papers)Tilman Todenhöfer (9 shared papers)Jens Bedke (8 shared papers)Mathias Busch (1 shared paper)Svea Petersen (1 shared paper)Raila Busch (1 shared paper)Anne Strohbach (1 shared paper)
- Journals
- Expert Opinion on Biological Therapy (2 papers)Cells (2 papers)Nature Communications (1 paper)Blood Cancer Journal (1 paper)Journal of the mechanical behavior of biomedical materials (1 paper)
- Partner nations
- GermanySwitzerlandCanada
In The Last Decade
Simon Walz
26 papers receiving 423 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 75
- Oncology 103
- Immunology 73
- Surgery 142
- Hematology 27
Countries citing papers authored by Simon Walz
This map shows the geographic impact of Simon Walz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Walz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Walz more than expected).
Fields of papers citing papers by Simon Walz
This network shows the impact of papers produced by Simon Walz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Walz. The network helps show where Simon Walz may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Walz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 116 | |
| 2 | 2015 | 74 | |
| 3 | 2013 | 65 | |
| 4 | 2018 | 21 | |
| 5 | 2020 | 19 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 13 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 10 | |
| 11 | 2020 | 8 | |
| 12 | 2017 | 8 | |
| 13 | 2018 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2020 | 3 |
About Simon Walz
Simon Walz is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 28 papers that have together received 424 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (11 papers), Immunotherapy and Immune Responses (4 papers), Urinary and Genital Oncology Studies (4 papers), Cancer Cells and Metastasis (3 papers), Prostate Cancer Treatment and Research (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (75 citations), Oncology (103 citations), Immunology (73 citations), Surgery (142 citations) and Hematology (27 citations). Simon Walz has collaborated with scholars based in Germany, Switzerland and Canada. Frequent co-authors include Arnulf Stenzl, Moritz Maas, Tilman Todenhöfer, Jens Bedke, Mathias Busch, Svea Petersen, Raila Busch, Anne Strohbach, Viktoria Stühler and Stephan B. Felix. Their work appears in journals such as Expert Opinion on Biological Therapy, Cells, Nature Communications, Blood Cancer Journal and Journal of the mechanical behavior of biomedical materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.